The March 2021 quarter result from Solara Active Pharma Sciences (CMP: Rs 1,694; Market Cap: Rs 6,069 crore) showed a sharp ramp-up in the new Vizag facility. It also indicates that Phase II expansion into niche APIs (Active Pharmaceutical Ingredients) should come in handy to meet increased product inquiries, wherein clients are looking for diversification of supply chain, away from China. In addition, the recent acquisition of Aurore Life Science strengthens the company’s APIs and CRAMS (Contract Research and Manufacturing Services)...
Moneycontrol Pro Panorama | Banking crisis in US and Europe holds valuable lessons
Mar 21, 2023 / 03:03 PM IST
In today’s edition of Moneycontrol Pro Panorama: Electricity usage likely to scale up this summer, US Fed needs to patch up infl...
Read NowMoneycontrol Pro Weekender: Between the Fed and a hard place
Mar 11, 2023 / 11:38 AM IST
The Fed is caught between combating inflation and worries over a financial mishap
Read NowTo read the full story, Subscribe to Moneycontrol PRO
Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience
Already a member? Sign in
Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to
Ad free experience
Experience a non-intrusive navigation and faster response in the ad free mode
Sharpest Opinions
Access to 230+ exclusive stories per month from our editorial and Experts
+
Have a Global edge with access to content from world renowned experts and journalist
Actionable Insights
Access to 40+ weekly investment ideas including 4 daily technical calls
Virtual Events
Exclusive access to live webinars from market experts on trading and investment strategies
Newsletters
Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.
Get upto 50% discount on limited period offers